Clinical Trials Browser

Phase NA × Leukemia × Imatinib Mesylate × Clear all

NCT00386373 2012-08-01

Use and Tolerability of Imatinib Mesylate (Gleevec) in Leukemia Patients

Phase NA Completed

MyeloidOther hematologic neoplasm

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive